Bluejay Diagnostics (BJDX) Notes Payables (2020 - 2024)

Bluejay Diagnostics has disclosed Notes Payables across 3 years of filings, most recently posting $147440.0 for Q2 2024.

• Notes Payables for Q2 2024 came in at $147440.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was $147440.0 (changed N/A YoY), and the FY2021 annual result was $10000.0, down 32.09% from the prior year.
• Notes Payables came in at $147440.0 for Q2 2024 at Bluejay Diagnostics, up from $10000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $147440.0 in Q2 2024 to a low of $10000.0 in Q3 2021.
• The 3-year median for Notes Payables is $12362.5 (2020), against an average of $45541.2.
• Peak annual rise in Notes Payables reached 32.09% in 2021, while the deepest fall reached 32.09% in 2021.
• Bluejay Diagnostics' Notes Payables stood at $14725.0 in 2020, then slumped by 32.09% to $10000.0 in 2021, then soared by 1374.4% to $147440.0 in 2024.
• The last three Notes Payables figures came in at $147440.0 (Q2 2024), $10000.0 (Q4 2021), and $10000.0 (Q3 2021), per Business Quant data.